L

Lexicon Pharmaceuticals
D

LXRX

0.65140
USD
-0.01
(-1.24%)
مغلق
حجم التداول
38,180
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
236,574,149
أصول ذات صلة
ABBV
ABBV
0.810
(0.44%)
183.260 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
BMY
BMY
-0.140
(-0.30%)
46.870 USD
GSK
GSK
-0.560
(-1.43%)
38.690 USD
JNJ
JNJ
0.360
(0.24%)
152.930 USD
LLY
LLY
-7.85
(-1.09%)
713.61 USD
MRK
MRK
-0.220
(-0.28%)
77.600 USD
NVO
NVO
-1.700
(-2.46%)
67.310 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
REGN
REGN
-8.04
(-1.35%)
588.61 USD
المزيد
الأخبار المقالات

العنوان: Lexicon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.